[1] 秦余香.高级分子生物学技术教学改革研究[J].教育教学论坛,2020(52):144-145.
[2] 薛启羹.分子神经生物学与神经病学的联系[J].中华神经精神科杂志,1995,28(1):46-47.
[3] 温进坤,韩梅.医学分子生物学理论与研究技术[M].北京:科学出版社,2002:445-450.
[4] 陈春华,陈继华,黄琼,等.睡眠剥夺介导神经元自噬抑制对小鼠抑郁样行为和认知功能的影响[J].东南大学学报:医学版,2021,40(5):657-665.
[5] 尹维民.神经内科学发展现状和展望[J].解放军医药杂志,2013(4):6-8.
[6] 刘振聪,王佰达.现在分子生物学技术在医学检验中的效果探究[J].特别健康,2020(21):44-45.
[7] 李春华,朱述阳,李家树,等.阻塞性睡眠呼吸暂停低通气综合征患者血清瘦素与白细胞介素6的关系研究[J].现代医学,2013(12):881-885.
[8] 王淋.分子生物学技术在医学检验中的应用进展[J].临床检验杂志,2020,9(1):243-244.
[9] 高纺,李丹,余新雅,等.实时荧光定量PCR技术及其在肿瘤研究中的应用[J].医学理论与实践,2020,33(19):3164-3165.
[10] WANG Z,XU P,CHEN B,et al.Identifying circRNA-associated-ceRNA networks in the hippocampus of Aβ1-42-induced Alzheimer's disease-like rats using microarray analysis[J].Aging (Albany NY).2018,10(4):775-788.
[11] ZHANG H,CHEN G,QIU W,et al.Plasma endothelial microvesicles and their carrying miRNA-155 serve as biomarkers for ischemic stroke[J].J Neurosci Res,2020,98(11):2290-2301.
[12] 周运鹤,许艺明,张成,等.单分子荧光原位杂交技术在面肩肱型肌营养不良症精准诊断中的应用研究[J].中国临床神经科学,2018(3):269-280.
[13] VAN-SCHEPPINGEN J,IYER A M,PRABOWO A S,et al.Expression of microRNAs miR21,miR146a,and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures[J].Glia,2016,64(6):1066-1082.
[14] 田培超,王越,史丹丹,等.二代测序技术在杜氏肌营养不良症家系中的分子诊断应用[J].中国当代儿科杂志,2019,21(3):244-248.
[15] 刘丽芝,廖忠,刘佳,等.经mNGS诊断的CNS诺卡菌感染三例[J].新医学,2019,50(1):61-65.
[16] MACKAY A,BURFORD A,CARVALHOD,et al.Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma[J].Cancer Cell,2017,32(4):520-537.
[17] SRIVASTAVA S,LOVE-NICHOLS J A,DIES K A,et al.Meta-analysis and multidis-ciplinary consensus statement:exome sequencing is a first-tier clinical diagnostictest for individuals with neurodevelopmental disorders[J].Genet Med,2019,21(11):2413-2421.
[18] HAMDAN F F,MYERS C T,COSSETTEP,et al.High rate of recurrent de novo mutations in developmental and epileptic encephalopathies[J].Am J Hum Genet,2017,101(5):664-685.
[19] 卢莎,张治芬.与绝经年龄相关的差异甲基化位点筛选及其与抑郁关联基因的初步分析[J].全科医学临床与教育,2020,18(9):781-784.
[20] 王娅,刘璐璐,张中兴,等.东莞地区脑梗死患者CYP2C19相关基因多态性分布及治疗指导价值探讨[J].医药前沿,2020,10(17):120-122.
[21] CHEN Q L,XIA L,ZHONG S P,et al.Bioinformatic analysis identifies key transcriptome signatures in temporal lobe epilepsy[J].CNS Neurosci Ther,2020,26(12):1266-1277.
[22] ZHOU L,PENG R,ZHANG R,et al.The applications of CRISPR/Cas system in molecular detection[J].J Cell Mol Med,2018,22(12):5807-5815.
[23] KUNKLEB W,GRENIER-BOLEY B,SIMS R,et al.Genetic Meta-analysis of dia-gnosed Alzheimer's disease identifies new risk loci and implicates Aβ,tau,immunity and lipid processing[J].Nat Genet,2019,51(3):414-430.
[24] DEMONTIS D,WALTERSR K,MARTIN J,et al.Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder[J].Nat Genet,2019,51(1):63-75.
[25] 王柠.神经遗传病的基因治疗策略与前景[N].中华医学信息导报,2018,33(23):11.
[26] SHI J B,WANG D Y,XIA Q,et al.The effects of m6A modification in central nervous system function and disease[J].Yi Chuan,2020,42(12):1156-1167.
[27] MENDELL J R,AL-ZAIDY S,SHELL R,et al.Single-dose gene-replacement Therapy for spinal muscular atrophy[J].N Engl J Med,2017,377(18):1713-1722.
[28] VALENCIA-GARCIA S,LIBOUREL P A,LAZARUS M,et al.Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder[J].Brain,2017,140(2):414-428.
[29] 文冬妮,叶钦勇.CHCHD2与神经系统疾病的研究进展[J].国际神经病学神经外科学杂志,2019,46(5):585-587.
[30] 付青贤.热休克蛋白60在神经系统疾病作用的研究进展[J].国际神经病学神经外科学杂志,2019,46(3):341-345.
[31] ULE J,BLENCOWE B J.Alternative splicing regulatory networks:functions,mechanisms,and evolution[J].Mol Cell,2019,76(2):329-345.
[32] SILANTYEV A S,FALZONE L,LIBRA M,et al.Current and future trends on diagnosis and prognosis of glioblastoma:from molecular biology to proteomics[J].Cells,2019,8(8):863. |
